WebApr 12, 2024 · The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. BIO-TECHNE Corp Stock Price History. BIO-TECHNE Corp’s price is currently up 9.48% so far this month. During the month of April, BIO-TECHNE Corp’s stock price has reached a high of $81.24 and a low ... WebJun 25, 2024 · Bio-Techne's management team will hold a conference call tomorrow, June 26, 2024 at 8:00 am CDT to discuss the Exosome Diagnostics acquisition. Interested parties may listen to the conference call by dialing 800-263-0877 or 646-828-8143 (for international callers) and referencing conference ID: 7186638.
TECH Stock Price Bio-Techne Corp. Stock Quote (U.S.: Nasdaq ...
WebBio-Techne Corporation's (NASDAQ:TECH) recent US$602m market cap decline means a loss of US$6.2k for insiders who bought this year. Simply Wall St. Aug-30-22 07:00AM. … WebApr 9, 2024 · The biotechnology company reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.03). Bio-Techne had a net margin of 23.38% and a return ... rachel belleson
Bio-Techne Corp Share Price Ordinary USD0.01 - Hargreaves Lansdown
WebMar 31, 2024 · Currently, BIO-TECHNE Corp’s price-earnings ratio is 46.2. BIO-TECHNE Corp’s trailing 12-month revenue is $1.1 billion with a 23.4% profit margin. Year-over-year quarterly sales growth most recently was 0.9%. Analysts expect adjusted earnings to reach $2.013 per share for the current fiscal year. BIO-TECHNE Corp currently has a 0.4% ... WebAug 5, 2024 · Delivered adjusted earnings per share (EPS) of $1.87 versus $1.00 one year ago. Full year GAAP EPS was $3.47 vs $5.82 one year ago. Full year adjusted EPS was $6.75 vs $4.55 in the prior year. ... the impact of the growing number of producers of biotechnology research products and related price competition, general economic … WebApr 6, 2024 · According to the issued ratings of 9 analysts in the last year, the consensus rating for Bio-Techne stock is Moderate Buy based on the current 2 hold ratings and 7 buy ratings for TECH. The average twelve-month price prediction for Bio-Techne is $104.36 with a high price target of $120.00 and a low price target of $88.00. shoe sensation black friday sale